Valar AIValar AI
Valar AI

Valar AI

AI-driven diagnostics company predicting cancer treatment response from pathology slides.

2026Active28
About
Valar Labs develops AI-powered diagnostics that analyze pathology slides to predict cancer treatment response. Their technology, exemplified by the Vesta platform for bladder cancer, aims to reduce uncertainty in treatment decisions and personalize care for patients. The company collaborates with healthcare providers and pharmaceutical companies to advance precision oncology.

Technology stack

detected 2026-05-21
CDN
Vercel
EmailGoogle Workspace
Hosting
Vercel
Stack
Next.js
Performance

Company Timeline

Frequently asked

What does Valar AI do?

Valar Labs develops AI-powered diagnostics that analyze pathology slides to predict cancer treatment response. Their technology, exemplified by the Vesta platform for bladder cancer, aims to reduce uncertainty in treatment decisions and personalize care for patients. The company collaborates with healthcare providers and pharmaceutical companies to advance precision oncology.

How much funding has Valar AI raised?

Valar AI has raised a total of $2.4B in funding. The most recent round on record is Series A.

Where is Valar AI headquartered?

Valar AI is headquartered in תל אביב - יפו, Israel.

When was Valar AI founded?

Valar AI was founded in 2026.

What industry does Valar AI operate in?

Valar AI operates in Fintech, Venture Capital, Payments, Digital Payments, Financial Services, Investment Firm.

How many employees does Valar AI have?

Valar AI has approximately 28 people on record.